ArticleOpen forum infectious diseases2022

Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study.

Steven E Coutre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.